Nordicubio/A型流感,喀里多尼亚(H1N1)/X2567

价格
面议
货号:X2567
浏览量:63
品牌:Nordic
服务
全国联保
正品保证
正规发票
签订合同
商品描述
InfluenzaA,Caledonia(H1N1)Cataloguenumber:X2567

ProductTypeInactivatedVirus
Units100µg
HostAllantoicfluid
ApplicationELISAImmunogen

BackgroundInfluenzavirusisasingle-strandedRNAvirus,segmented,70nmindiameterandenveloped.Strainsaredescribedbygeographicorigin,strainnumber,yearofisolationandhemagglutination(H)andneuraminidase(N)antigens.

Source

Immunogen:Allantoicfluidof10daysoldembryonatedeggs,inoculatedwithinfluenzaAvirus,strainA/NewCaledonia/20/99IVR116.TheInfluenzaViruswaspurifiedbyUltracentrifugationwith10-40%sucrosegrADIent.

Product

Formulation:SuppliedasaliquidinSTE,0.1%sodiumazide,0.005%merthiolate.

PurificationMethod:PurifiedbyRP-HPLC,FPLC,orreducing/non-reducingSDS-PAGESilverStain;Purifiedbyultracentrifugationusing10-40%sucrosegradient.

Purity:?90%

Concentration:Seevialforconcentration

ApplicationsHasbeentestedwithanti-influenzaAmonoclonalantibodiesinELISA.InactivateedbyThimerosalandbetapropiolactonetreatmentOptimalconcentrationshouldbeevaluatedbyserialdilutions.

FunctionalAnalysis:ELISA

StorageMaybestoredat4°Cforshort-termonly.Forlong-termstorageandtoavoidrepeatedfreezingandthawing,aliquotandstoreat-20°C

ProductStABIlity:Productsarestableforoneyearfrompurchasewhenstoredproperly

ShippingConditions:BlueIce

CautionThisproductisintendedFORRESEARCHUSEONLY,andFORTESTSINVITRO,notforuseindiagnosticortherapeuticproceduresinvolvinghumansoranimals.Itmaycontainhazardousingredients. PleaserefertotheSafetyDataSheets(SDS)foradditionalinformationandproperhandlingprocedures.Disposeproductremaindersaccordingtolocalregulations.Thisdatasheetisasaccurateasreasonablyachievable,butNordic-Mubio​acceptsnoliabilityforanyinaccuraciesoromissionsinthisinformation.

SafetyDatasheet(s)forthisproduct:NM_SodiumAzide/wp-content/uploads/SDS/AntibodySDSwithSodiumAzideNoridic-MUbio.pdf

Nordic-MUbio开发和生产用于研发的高质量抗体试剂。我们所有的产品都是按照严格的ISO 9001质量准则生产的,我们的重点是开发针对细胞粘附,核蛋白和细胞骨架蛋白的抗体。Nordic-MUbio是开发用于斑马鱼研究抗体的领先抗体公司之一-我们目前已经验证了超过50种斑马鱼免疫荧光的抗体。在专有和合作开发计划中,Nordic-MUbio正在研究,测试和验证专利的抗体和抗原,用于肺癌和其他癌症领域的诊断应用。为了扩展其抗体和诊断应用产品的范围,Nordic-MUbio不断与不同的学术机构和研究小组保持密切联系,以选择其他机会:如果您对产品许可感兴趣,请发送电子邮件至info@nordicmubio.com。